Journal of Cutaneous Pathology · 2011 · 65 citations · 22 references
MedicineOncologyPathologyCancer GeneticsCutaneous OncologyHistopathologyCancer DetectionMelanocytic LesionsMelanocytic TumorsTumor CharacterizationTumor DetectionTumor DifferentiationAssayBlue NeviCellular Blue NevusConventional MicroscopyHistopathologic ExaminationHistopathologic InterpretationMelanocytic Tumor Differential DiagnosisMelanoma Diagnosis
BACKGROUND: Blue nevus-like melanomas are melanomas that arise in association with blue nevi or closely simulate the histopathologic appearance of a blue nevus, usually a cellular blue nevus (CBN). Although the majority of CBN can be readily distinguished from blue nevus-like melanoma by conventional microscopy, there are a subset of cases where this distinction may be exceedingly difficult or impossible. METHODS: In this study, we evaluated the ability of a fluorescence in situ hybridization (FISH) assay targeting 6p25 (RREB1), 6q23 (MYB), 11q13 (CCND1) and the centromere of chromosome 6 (Cep6) to distinguish between CBN and blue nevus-like melanoma. We identified five cases of blue nevus-like melanoma and 12 cases of CBN. RESULTS: The FISH assay was performed with 100% sensitivity and 100% specificity. Three of five cases met the 6p25/Cep6 criteria, all five met the 6p25 gain criteria and three of five met the 6q23/Cep6 loss criteria. None of the cases met criteria for gains in 11q13. None of the 12 CBN met any criteria for melanoma. CONCLUSIONS: A combined analysis of clinical aspects, histopathologic changes and FISH analysis could potentially contribute significantly to the ability of pathologists to discriminate between blue nevus-like melanoma and blue nevi in challenging cases.
22
Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi
Catherine D. Van Raamsdonk, Vladimir Bezrookove, Gary Green et al. · Nature · 2008 · 1.6K citations · Full text
Raymond L. Barnhill, Zsolt B. Argényi, Marianne Berwick et al. · The American Journal of Surgical Pathology · 2008 · 136 citations
Medicine, Dermatology, Pathology +17